PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
AZN vs. CAH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


AZNCAH
YTD Return15.10%-1.44%
1Y Return4.91%24.91%
3Y Return (Ann)15.59%20.28%
5Y Return (Ann)17.65%18.65%
10Y Return (Ann)10.41%7.49%
Sharpe Ratio0.211.12
Daily Std Dev22.23%21.22%
Max Drawdown-48.94%-61.69%
Current Drawdown-0.08%-14.07%

Fundamentals


AZNCAH
Market Cap$233.06B$25.10B
EPS$2.02$2.52
PE Ratio37.2140.96
PEG Ratio0.890.31
Revenue (TTM)$47.61B$216.15B
Gross Profit (TTM)$35.73B$6.55B
EBITDA (TTM)$15.80B$2.73B

Correlation

-0.50.00.51.00.3

The correlation between AZN and CAH is 0.27, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

AZN vs. CAH - Performance Comparison

In the year-to-date period, AZN achieves a 15.10% return, which is significantly higher than CAH's -1.44% return. Over the past 10 years, AZN has outperformed CAH with an annualized return of 10.41%, while CAH has yielded a comparatively lower 7.49% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


3,500.00%4,000.00%4,500.00%5,000.00%5,500.00%6,000.00%December2024FebruaryMarchAprilMay
4,269.85%
5,192.13%
AZN
CAH

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


AstraZeneca PLC

Cardinal Health, Inc.

Risk-Adjusted Performance

AZN vs. CAH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for AstraZeneca PLC (AZN) and Cardinal Health, Inc. (CAH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


AZN
Sharpe ratio
The chart of Sharpe ratio for AZN, currently valued at 0.21, compared to the broader market-2.00-1.000.001.002.003.004.000.21
Sortino ratio
The chart of Sortino ratio for AZN, currently valued at 0.43, compared to the broader market-4.00-2.000.002.004.006.000.43
Omega ratio
The chart of Omega ratio for AZN, currently valued at 1.06, compared to the broader market0.501.001.501.06
Calmar ratio
The chart of Calmar ratio for AZN, currently valued at 0.24, compared to the broader market0.002.004.006.000.24
Martin ratio
The chart of Martin ratio for AZN, currently valued at 0.46, compared to the broader market-10.000.0010.0020.0030.000.46
CAH
Sharpe ratio
The chart of Sharpe ratio for CAH, currently valued at 1.12, compared to the broader market-2.00-1.000.001.002.003.004.001.12
Sortino ratio
The chart of Sortino ratio for CAH, currently valued at 1.58, compared to the broader market-4.00-2.000.002.004.006.001.58
Omega ratio
The chart of Omega ratio for CAH, currently valued at 1.22, compared to the broader market0.501.001.501.22
Calmar ratio
The chart of Calmar ratio for CAH, currently valued at 1.68, compared to the broader market0.002.004.006.001.68
Martin ratio
The chart of Martin ratio for CAH, currently valued at 5.32, compared to the broader market-10.000.0010.0020.0030.005.32

AZN vs. CAH - Sharpe Ratio Comparison

The current AZN Sharpe Ratio is 0.21, which is lower than the CAH Sharpe Ratio of 1.12. The chart below compares the 12-month rolling Sharpe Ratio of AZN and CAH.


Rolling 12-month Sharpe Ratio0.001.002.003.00December2024FebruaryMarchAprilMay
0.21
1.12
AZN
CAH

Dividends

AZN vs. CAH - Dividend Comparison

AZN's dividend yield for the trailing twelve months is around 1.90%, less than CAH's 2.02% yield.


TTM20232022202120202019201820172016201520142013
AZN
AstraZeneca PLC
1.90%2.15%2.14%2.40%2.80%2.81%3.61%3.95%5.01%4.06%3.98%4.72%
CAH
Cardinal Health, Inc.
2.02%1.98%2.57%3.80%3.62%3.80%4.24%3.00%2.41%1.68%1.65%1.77%

Drawdowns

AZN vs. CAH - Drawdown Comparison

The maximum AZN drawdown since its inception was -48.94%, smaller than the maximum CAH drawdown of -61.69%. Use the drawdown chart below to compare losses from any high point for AZN and CAH. For additional features, visit the drawdowns tool.


-20.00%-15.00%-10.00%-5.00%0.00%December2024FebruaryMarchAprilMay
-0.08%
-14.07%
AZN
CAH

Volatility

AZN vs. CAH - Volatility Comparison

The current volatility for AstraZeneca PLC (AZN) is 6.08%, while Cardinal Health, Inc. (CAH) has a volatility of 7.41%. This indicates that AZN experiences smaller price fluctuations and is considered to be less risky than CAH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%5.00%6.00%7.00%8.00%December2024FebruaryMarchAprilMay
6.08%
7.41%
AZN
CAH

Financials

AZN vs. CAH - Financials Comparison

This section allows you to compare key financial metrics between AstraZeneca PLC and Cardinal Health, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items